“…Adipokines are involved in glucose metabolism (e.g., adiponectin, leptin, resistin, visfatin, and PAI-1 [ 5 , 6 ]), inflammation (e.g., resistin and leptin [ 7 ]), reducing inflammation (e.g., adiponectin [ 5 , 7 ]), coagulation (e.g., PAI-1 [ 6 ]), endothelial dysfunction (e.g., PAI-1 [ 8 ]), and feeding behavior (e.g., leptin [ 6 ]). In addition, adiponectin augments energy expenditure [ 9 ]. With regard to epidemiological evidence, high concentrations of leptin [ 10 ], resistin [ 11 ], visfatin [ 12 ], and PAI-1 [ 8 , 13 ] have been associated with an increased risk of type 2 diabetes, whereas high adiponectin concentrations have been associated with a decreased risk of obesity [ 6 ] and type 2 diabetes [ 14 , 15 ].…”